Author Correction: Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection (Nature Immunology, (2017), 18, 11, (1261-1269), 10.1038/ni.3849);Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection

Nature Immunology

Volumn 18, Issue 11, 2017, Pages 1261-1269

  Fernandez, Estefania ^a   Dejnirattisai, Wanwisa ^b   Cao, Bin ^a   Scheaffer, Suzanne M ^a   Supasa, Piyada ^b   Wongwiwat, Wiyada ^b   Esakky, Prabagaran ^a   Drury, Andrea ^a   Mongkolsapaya, Juthathip ^b,c   Moley, Kelle H ^a   Mysorekar, Indira U ^a   Screaton, Gavin R ^b,d   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HUMAN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EDE1 B10; MONOCLONAL ANTIBODY EDE1 C8; MONOCLONAL ANTIBODY EDE2 A11; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RNA; EPITOPE; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SECRETING CELL; ANTIGEN BINDING; ARTICLE; BLOOD TESTIS BARRIER; BRAIN; CONTROLLED STUDY; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; EC50; EPIDIDYMIS; FEMALE; FETUS; FETUS OUTCOME; FETUS TISSUE; IN VITRO STUDY; INFECTION CONTROL; MALE; MATERNAL SERUM; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SPERMATOZOON COUNT; VIRUS INHIBITION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; ZIKA FEVER; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; CLASSIFICATION; CROSS REACTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; SERODIAGNOSIS; TESTIS; VERO CELL LINE; VIROLOGY; ZIKA VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BRAIN; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; DENGUE VIRUS; EPITOPES; FEMALE; FETUS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MICE; NEUTRALIZATION TESTS; PREGNANCY; PROTEIN MULTIMERIZATION; TESTIS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85031797326     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-019-0560-5     Document Type: Erratum

References (55)

1. Weaver, S. C. et al. Zika virus: History, emergence, biology, and prospects for control. Antiviral Res. 130, 69-80 (2016).
2. Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321-2334 (2016).
3. Schaub, B. et al. Analysis of blood from Zika-virus-infected fetuses: A prospective case series. Lancet Infect. Dis. 3099, 26-28 (2017).
4. Honein, M. A. et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. J. Am. Med. Assoc. 317, 59-68 (2017).
5. Cao-Lormeau, V.-M. et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet 387, 1531-1539 (2016).
6. Parra, B. et al. Guillain-Barré Syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375, 1513-1523 (2016).
7. Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696-704 (2016).
8. Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725 (2002).
9. Dowd, K. A. et al. Broadly neutralizing activity of Zika-virus-immune sera identifies a single viral serotype. Cell Rep. 16, 1485-1491.
10. Barba-Spaeth, G. et al. Structural basis of potent Zika-dengue virus antibody crossneutralization. Nature 536, 48-53 (2016).
11. Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170-177 (2015).
12. Fernandez, E. & Diamond, M. S. Vaccination strategies against Zika virus. Curr. Opin. Virol. 23, 59-67 (2017).
13. Nelson, S. et al. Maturation of West Nile virus modulates sensitivity to antibodymediated neutralization. PLoS Pathog. 4, e1000060 (2008).
14. Kam, Y.-W. et al. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight 2, http://dx. doi. org/10. 1172/jci. insight. 92428 (2017).
15. Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S. & Mosser, D. M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect. Dis. 10, 712-722 (2010).
16. Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. 17, 1102-1108 (2016).
17. Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823-826 (2016).
18. Zhao, H. et al. Structural basis of Zika-virus-specific antibody protection. Cell 166, 1016-1027 (2016).
19. Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443-447 (2016).
20. Robbiani, D. F. et al. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169, 597-609 (2017).
21. Wang, Q. et al. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci. Transl. Med. 8, 369ra179 (2016).
22. Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio 7, e01116-e23 (2016).
23. Hirsch, A. J. et al. Zika virus infection of rhesus macaques leads to viral persistence in multiple tissues. PLoS Pathog. 13, e1006219 (2017).
24. Miner, J. J. et al. Zika Virus infection in mice causes panuveitis with shedding of virus in tears. Cell Rep. 16, 3208-3218 (2016).
25. Bhatnagar, J. et al. Zika virus RNA replication and persistence in brain and placental tissue. Emerg. Infect. Dis. 23, 405-414 (2017).
26. Aid, M. et al. Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys. Cell 169, 610-620 (2017).
27. Govero, J. et al. Zika virus infection damages the testes in mice. Nature 540, 438-442 (2016).
28. Ma, W. et al. Zika virus causes testis damage and leads to male infertility in mice. Cell 167, 1511-1524 (2016).
29. Yockey, L. J. et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247-1256 (2016).
30. Rouvinski, A. et al. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat. Commun. 8, 15411 (2017).
31. Pierson, T. C. & Diamond, M. S. A game of numbers: The stoichiometry of antibodymediated neutralization of flavivirus infection. Prog. Mol. Biol. Transl. Sci. 129, 141-166 (2015).
32. Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101-104 (2007).
33. Magdelaine-Beuzelin, C., Pinault, C., Paintaud, G. & Watier, H. Therapeutic antibodies in ophthalmology: old is new again. MAbs 2, 176-180 (2010).
34. Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081-1091 (2016).
35. Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267-271 (2016).
36. Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880-882 (2011).
37. Musso, D. et al. Potential sexual transmission of Zika virus. Emerg. Infect. Dis. 21, 359-361 (2015).
38. Russell, K. et al. Male-to-female sexual transmission of Zika virus-United States, January-April 2016. Clin. Infect. Dis. 64, 211-213 (2017).
39. Davidson, A., Slavinski, S., Komoto, K., Rakeman, J. & Weiss, D. Suspected femaleto-male sexual transmission of Zika virus-New York City, 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 716-717 (2016).
40. Deckard, D. T. et al. Male-to-male sexual transmission of Zika virus-Texas, January 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 372-374 (2016).
41. Barzon, L. et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill. 21, 30316 (2016).
42. Richner, J. M. et al. Vaccine-mediated protection against Zika-virus-induced congenital disease. Cell 170, 273-283 (2017).
43. Sukupolvi-Petty, S. et al. Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J. Virol. 87, 8826-8842 (2013).
44. Mansuy, J. M. et al. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen Lancet Infect. Dis. 16, 405 (2016).
45. Murray, K. O. et al. Prolonged detection of Zika virus in vaginal secretions and whole blood. Emerg. Infect. Dis. 23, 99-101 (2017).
46. Zeitlin, L. et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl. Acad. Sci. USA 108, 20690-20694 (2011).
47. DiLillo, D. J., Tan, G. S., Palese, P. & Ravetch, J. V. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcR interactions for protection against influenza virus in vivo. Nat. Med. 20, 143-151 (2014).
48. Hiatt, A. et al. Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc. Natl. Acad. Sci. USA 111, 5992-5997 (2014).
49. Carroll, T. et al. Zika virus preferentially replicates in the female reproductive tract after vaginal inoculation of rhesus macaques. PLoS Pathog. 13, e1006537 (2017).
50. Halstead, S. B. Biologic evidence required for Zika disease enhancement by dengue antibodies. Emerg. Infect. Dis. 23, 569-573 (2017).
51. Brien, J. D., Lazear, H. M. & Diamond, M. S. Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol. 31, 15D. 3. 1-15D. 3. 18 (2013).
52. National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, 2011).
53. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232-1239 (2008).
54. Hansen, D. A., Esakky, P., Drury, A., Lamb, L. & Moley, K. H. The aryl hydrocarbon receptor is important for proper seminiferous tubule architecture and sperm development in mice. Biol. Reprod. 90, 8 (2014).
55. Goodson, S. G., Zhang, Z., Tsuruta, J. K., Wang, W. & O'Brien, D. A. Classification of mouse sperm motility patterns using an automated multiclass support vector machines model. Biol. Reprod. 84, 1207-1215 (2011).